TY  - CONF

T1  - Flotetuzumab As Salvage Therapy for Primary Induction Failure and Early Relapse Acute Myeloid Leukemia

JO  - Blood

UR  - https://doi.org/10.1182/blood-2020-134576

PY  - 2020/11/05

AU  - Aldoss I

AU  - Uy GL

AU  - Vey N

AU  - Emadi A

AU  - Sayre PH

AU  - Walter RB

AU  - Foster MC

AU  - Arellano ML

AU  - Godwin JE

AU  - Wieduwilt MJ

AU  - Byrne MT et al

ED  - 

DO  - DOI: 10.1182/blood-2020-134576

PB  - American Society of Hematology

VL  - 136

IS  - Supplement 1

SP  - 16

EP  - 18

Y2  - 2026/02/25

ER  -